专利详细信息
专利号 | SK288053B6 |
专利标题 | Combination comprising 5-[4-[2-(n-methyl-n-(2- pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione and sub maximal amount of sulphonylurea |
专利权人 | SMITHKLINE BEECHAM PLC; |
发明人 | Buckingham, Robin Edwin;Smith, Stephen Alistair; |
申请号 | SK20050000089 |
申请日 | 1998/7/16 |
公开日 | 2013/3/1 |
优先权号 | |
IPC | A61K03144390; |
专利类型 | |
法律状态查询 | 查看法律状态 |
A combination comprising 2 to 8 mg of 5-[4-[2-(N-methyl-N- (2-pyridyl)amino)-ethoxy]benzyl]thiazolidine-24-dione (rosiglitazone) or a tautomeric form thereof or a pharmaceutically acceptable salt or solvate thereof; and sub maximal amount of sulphonylurea selected from glibenclamide glipizide gliclazide tolazamide tolbutamide acetohexamide carbutamide chlorpropamide glibornuride gliquidone glisentide glisolamide glisoxepide glyclopyamide and glycylamide. Disclosed is also a medical use of the combination and pharmaceutical composition comprising it. The combination is intended for the treatment of diabetes mellitus and conditions associated with diabetes mellitus.
没有相关的数据
没有相关的数据
暂无附图
注:除CN专利外,本系统默认提供的所有其他中文标题和摘要来自机器翻译。